Monoclonal anti-TNF antibodies may increase risk of herpes zoster

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1241, 2009-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-TNF antibodies linked to malignancy/serious infection

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

CDP 571: Anti-TNF monoclonal antibody, BAY 103356,

Drugs in R&D, Vol. 4, Iss. 3, 2003-01 ,pp. : 174-178

Adis International

Access to resources Recommend Favorite

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

By Avouac J Allanore Y

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1121-1128

Informa Healthcare

Access to resources Recommend Favorite

How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease

Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. : 198-218

Bentham Science Publishers

Access to resources Recommend Favorite

Utility of Measuring Serum Concentrations of Anti-TNF Agents and Anti-Drug Antibodies in Inflammatory Bowel Disease

Current Drug Metabolism, Vol. 12, Iss. 6, 2011-07 ,pp. : 594-598

Bentham Science Publishers

Access to resources Recommend Favorite